Givaudan's New CEO Draws a Line: Litigation and Tariffs Hit H1 Profits, but the 2030 Ambitions Stand

Adjusted EBITDA margin dips to 24.3% on extra CHF 103M of one-offs; management confirms medium-term targets and sees a sequential Taste & Wellbeing recovery.

GIVN.SW · Earnings Call · 2026-07-23

First Impressions: A Quarter of Adjustments

Christian Stammkoetter, in his debut half-year call as CEO, signaled continuity rather than revolution. Yet the numbers told a more nuanced story. Group sales rose 3.6% like-for-like to CHF 3,799 million, but reported net income fell 20% to CHF 475 million. The culprit: a hefty dose of non-recurring costs. The company booked CHF 83 million of litigation settlements and provisions, most notably a CHF 50 million settlement in Fragrance & Beauty over antitrust probes and a CHF 53 million provision in Taste & Wellbeing related to an adverse U.S. butter-flavor ruling. CFO Stewart Harris called the Missouri decision "exceptional and inconsistent with the broader litigation history," while acknowledging the company is "considering all available legal options." These items dragged adjusted EBITDA margin down to 24.3% from 25.2% a year earlier, and leverage ticked up to 2.8x net debt/EBITDA.

The adjusted EBITDA was CHF 923 million compared to CHF 973 million in the first half of 2025, a decrease of 5.2% in Swiss francs, where when measured in local currency, the adjusted EBITDA increased by 0.8%.
Stewart Harris, Chief Financial Officer · 2026-07-23

Settlement agreement and nonrecurring cost were understandably the quarter's most prominent keywords, marking a clear departure from the prior year's theme of onetime cost associated. The company framed these as one-offs, but the market will rightfully ask whether they signal a broader legal or regulatory overhang.

Taste & Wellbeing: A Sequential Step and a Structural Debate

Beyond the noise, the most encouraging operational data point was the sequential improvement in Taste & Wellbeing, which turned from -0.4% like-for-like in Q1 to +1.5% in Q2. Management attributes this to early wins from commercial actions and a healthier pipeline. Pipeline inflow and Food Service were cited as areas of focus, particularly in North America where the business remains under pressure. Stammkoetter acknowledged that consumer demand is "more volatile" and that "consumers remain selective, particularly at lower income levels," but he pointed to encouraging signs in reformulation, natural colors, and GLP-1-related briefs. “We see a good pipeline inflow, of course, also in natural colors. That is obviously, kind of the shift with the MAA movement towards natural colors.” — Christian Stammkoetter, Chief Executive Officer · 2026-07-23 Natural color has been a recurring theme for Givaudan, but it gained fresh momentum this quarter as the company positioned itself squarely behind the U.S. anti-synthetic-color movement. Management also reiterated its confidence in GLP 1 as a net positive — a view echoed by several other reporters in the recent tape, including open label study peers, reinforcing that this is a broader industry trend rather than a company-specific claim. The company's medium-term target of 4-6% like-for-like growth and >12% adjusted free cash flow margin was reconfirmed. But the H1 free cash flow of -CHF 119 million raised eyebrows. Harris attributed this to "temporary working capital effects and higher investments" and expects "a meaningful improvement in working capital by the end of the year." The net debt-to-EBITDA ratio of 2.8x, up from 2.1x at year-end, reflects the litigation charges weighing on EBITDA, but management insists this is a temporary blip.

Fragrance & Beauty: Still the Star, But Watch the Ingredients

Fragrance & Beauty delivered a strong 6.5% like-for-like growth, with Fine Fragrance up 7.3% and Consumer Products up 9.2%. However, Fragrance Ingredients and Active Beauty declined 4.1%, with management citing "price competition in parts of the portfolio." This echoes a concern from the prior call, where Gilles Andrier described Fragrance Ingredients as facing headwinds from Chinese competition. The difference now is that the company is framing it as a more persistent issue, even as it reassures that the broader fragrance complex remains resilient. “We see strong performance in local regions, but we also see strong performance in our global customers. We see in segments, when you look at Fabric Care, for example, we see continued strong momentum there.” — Christian Stammkoetter, Chief Executive Officer · 2026-07-23 Beauty sales and Active Beauty remain important contributors, but the divestiture by a key peer of botanical extracts and natural colorants naturally raised questions. Stammkoetter was diplomatic, saying the company will "not comment on disposals of assets from competitors," but he doubled down on the opportunity in natural colors, calling it "absolutely critical."

What Changed? The Numbers Tell the Story

The most material change is the step-up in one-off costs. In the prior year, the company highlighted CHF 19 million of such items; this quarter it jumped to CHF 103 million. That swing alone explains the entire decline in adjusted EBITDA margin. Without it, the margin would have been roughly 25.2%, in line with last year. The litigation provisions are not merely accounting artifacts—they could have structural implications if they reflect broader industry scrutiny. The company notes the antifragrance investigation is multi-jurisdictional, and the Missouri butter-flavor case is being appealed. The second change is the explicit mention of tariff refunds. Management stated they have "started to receive partial refunds of previously paid tariffs" and expect to pass these back to customers, offsetting the inflation-related pricing impact. This is a nuanced position: it suggests that while tariffs are a headwind, the company has pricing power and a mechanism to neutralize them. It also differentiates Givaudan from many industrial peers who are simply absorbing tariff costs. Finally, the tone from the new CEO is notably more cautious about the external environment than his predecessor's. Stammkoetter repeatedly referenced "geopolitical and macroeconomic uncertainty," yet also expressed confidence in the "resilience of our business model." This dual messaging reflects a leader who is still building his narrative while inheriting a strong franchise.

Why It Matters

Givaudan is the world's largest fragrance and flavor company, a bellwether for consumer spending on premium and everyday products alike. The H1 results show that the underlying demand engine is intact, with broad-based volume-led growth of 3.6%. But the profitability dip, driven by one-offs, and the working capital build, are precisely the kind of temporary factors that the market may overreact to. The sequential recovery in Taste & Wellbeing, if it continues, would be a significant positive for the stock, which has been in a drawdown over the past year. The keyword shift from Comparable EBITDA to nonrecurring cost and settlement agreement encapsulates the quarter's narrative. The company is consciously moving to a new adjusted metric basis ahead of IFRS 18, and this quarter's clean numbers will serve as the baseline. Investors should watch whether the legal overhang persists or fades, and whether the promised working capital improvement materializes by year-end. For now, Givaudan's core story—premiumization, natural ingredients, and global reach—remains intact, but the path to its stated 2030 ambitions now runs through a more litigation-prone and tariff-sensitive landscape.